Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.
about
Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregationRegenerative Capacity of Macrophages for RemyelinationThe Role of Toll-Like Receptor 4 in Infectious and Noninfectious InflammationThe role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?How do immune cells support and shape the brain in health, disease, and aging?A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's diseaseMicroglia development and functionImmunotherapeutic approaches for Alzheimer's diseaseAPOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspectiveRemodeling of lipid bodies by docosahexaenoic acid in activated microglial cellsTemporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β.Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathyNovel synthetic toll-like receptor 4/MD2 ligands attenuate sterile inflammationOpposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathwayAmyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.The morphological and molecular changes of brain cells exposed to direct current electric field stimulation.Alginate-Derived Oligosaccharide Inhibits Neuroinflammation and Promotes Microglial Phagocytosis of β-Amyloid.Progesterone and vitamin D combination therapy modulates inflammatory response after traumatic brain injury.Immunization with Small Amyloid-β-derived Cyclopeptide Conjugates Diminishes Amyloid-β-Induced Neurodegeneration in MiceAlzheimer's disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules.Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.Microglial dysfunction in brain aging and Alzheimer's diseaseAlzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease.Calcium regulation of neural rhythms, memory and Alzheimer's disease.Mast cells, glia and neuroinflammation: partners in crime?The innate immune system in Alzheimer's disease.Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis.Microglial Aβ receptors in Alzheimer's disease.The Role of TREM2 in Alzheimer's Disease and Other Neurological Disorders.Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research.The dynamics of monocytes and microglia in Alzheimer's disease.Developing therapeutic vaccines against Alzheimer's disease.Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease.Immunosenescence of microglia and macrophages: impact on the ageing central nervous system.Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.Lipid A structural modifications in extreme conditions and identification of unique modifying enzymes to define the Toll-like receptor 4 structure-activity relationship.Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.Strategies to increase the activity of microglia as efficient protectors of the brain against infections.
P2860
Q22001058-DB6E671D-B0CE-45DF-A613-3FA0814A0C15Q26744475-DCBCA02F-9E1D-4C94-805B-F1970D6FA3CCQ26747005-040F7B76-2173-49CB-AEE7-1634C78CC4AFQ26861263-E65E637E-10E6-47FA-B1BD-D31D639BB19AQ26995364-599D9F5F-51DF-46D0-890B-FC9C837A7C0DQ26997058-6127F49D-043B-4CF6-B329-0F21C9C1D95CQ27316453-C067BC2D-314A-427B-8198-9ACB94E6A5F8Q28081278-FC01B534-654D-43F5-8814-0896DAE92F2CQ28085213-F3FE7768-7F06-445B-901B-53258FC5B458Q28395128-9B31FB07-6061-453C-9083-52CAE68D63CBQ33359453-4BE6452D-62C5-4947-A452-059615DECEA9Q33739020-0DD9BA55-5D61-4E78-9EA3-E3DCE4D58486Q33868678-C890CE45-8A5C-4C0C-8459-975471A84684Q33944008-DFA796A6-91F2-4AFD-9350-9CFE2AC3E4A3Q34162803-F68D35AA-22A7-4F12-A11E-B96AB00489D4Q34227162-6FCB6C63-7165-4E5A-8BAB-3845BD9767F3Q35224286-2D3DB1CD-5FF2-427F-A018-3B7772C953E0Q36096572-13E516E0-A432-420E-8473-37F57C7046C1Q36973541-87CC1F8F-5913-4CDC-97F1-C77A9D180752Q37053799-7C1E0380-8189-4B2A-9A0F-757BE1A455CAQ37057272-51157F85-BB69-44BB-9F84-1E60939EE634Q37591996-461B0433-AD38-447C-BBF2-D46FCCF189E7Q37630548-5F9ACC3D-BBC0-4D70-99E9-069BBB886AD7Q37678533-C5EEF296-9A77-42FB-A29E-9B56E3EA2A47Q38108433-366B8133-F601-40DD-A503-F8AE428FBF63Q38113489-D5C710A1-D1E4-43E3-946A-0BE0EEB7F7E1Q38137173-22B5C3B0-3F82-4EA1-BF7E-98D8A80A33D8Q38162221-2F940D23-63AE-4945-BE80-5EDA53CAC1BBQ38195641-1DB119D4-1CD5-44F8-8D5B-2370429F9AD4Q38242383-0220E910-A635-4F16-B400-E2DC3728A5D8Q38348923-5B60CF37-A382-4BD0-B0E8-74914F469B30Q38388693-AA32F4D8-8D39-473B-BB6C-65183EB6CF92Q38423147-7AF1C9C1-42E7-4FBB-91A4-6AF33B357BEFQ38636151-94444E43-4698-4C8E-93B3-077DE5F47072Q38693735-FC211E81-FA7A-401A-8E2D-E0BA5903DC88Q38749164-B1AD2DA4-3286-4561-B816-1B4B09A356E9Q38808543-9BDC2AC9-7617-42AF-9FCC-3CAF473D7BFCQ39096977-9D9E71DB-80B1-475B-86B5-F10645A0C660Q39376524-019530DE-FE80-44FE-85FE-037E26839E82Q39924370-4132F94D-8DAA-4AE9-B414-1BB1B5C3B735
P2860
Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Toll-like receptor 4 stimulati ...... r's disease-related pathology.
@ast
Toll-like receptor 4 stimulati ...... r's disease-related pathology.
@en
type
label
Toll-like receptor 4 stimulati ...... r's disease-related pathology.
@ast
Toll-like receptor 4 stimulati ...... r's disease-related pathology.
@en
prefLabel
Toll-like receptor 4 stimulati ...... r's disease-related pathology.
@ast
Toll-like receptor 4 stimulati ...... r's disease-related pathology.
@en
P2093
P2860
P356
P1476
Toll-like receptor 4 stimulati ...... er's disease-related pathology
@en
P2093
Anne-Marie Lanteigne
Anthony Pilorget
Antoine Lampron
Christopher Cluff
Daniel Larocque
Maxime Hallé
Mohammed Filali
Pascale Tribout-Jover
Paul Préfontaine
Peter Thériault
P2860
P304
P356
10.1073/PNAS.1215165110
P407
P577
2013-01-15T00:00:00Z